World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
99
Citations
41147
World Ranking
743
National Ranking
424

Medicine

D-Index
99
Citations
41149
World Ranking
8516
National Ranking
4392

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Robert H. Vonderheide is affiliated with the University of Pennsylvania in the United States. Their research primarily focuses on medicine with an emphasis on oncology, immunology, molecular biology, and cancer research. Their extensive work spans key areas such as cancer immunotherapy, biomarkers, pancreatic and hepatic oncology, immune responses, and cancer genomics.

Their recent published papers include:

  • Challenges and Opportunities for Pancreatic Cancer Immunotherapy, 2020, Cancer Cell
  • CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer, 2021, Nature Medicine
  • Ferroptosis of tumour neutrophils causes immune suppression in cancer, 2022, Nature
  • Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer, 2022, Cancer Discovery
  • Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial, 2022, Nature Medicine

Frequent co-authors in their research collaborations include Mark H. O'Hara, Ben Z. Stanger, Katelyn T. Byrne, Nune Markosyan, and Rina Sor.

The scientist has published regularly in the following venues:

  • Cancer Research
  • Journal of Clinical Oncology
  • Cancer Immunology Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Discovery

Their work covers a variety of specialized topics such as:

  • Cancer Immunotherapy and Biomarkers
  • Pancreatic and Hepatic Oncology Research
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Cancer Genomics and Diagnostics
  • Immune cells in cancer
  • Economic and Financial Impacts of Cancer

Robert H. Vonderheide has been recognized with the distinction of Member of the Association of American Physicians.

Best Publications

  • Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

    Vincenzo Bronte;Sven Brandau;Shu Hsia Chen;Mario P. Colombo

  • Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

    Christina Twyman-Saint Victor;Andrew J. Rech;Amit Maity;Ramesh Rengan;Ramesh Rengan

  • EMT and Dissemination Precede Pancreatic Tumor Formation

    Andrew D. Rhim;Emily T. Mirek;Nicole M. Aiello;Anirban Maitra

  • CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans

    Gregory L. Beatty;Elena G. Chiorean;Matthew P. Fishman;Babak Saboury

  • T-cell invigoration to tumour burden ratio associated with anti-PD-1 response

    Alexander C. Huang;Michael A. Postow;Michael A. Postow;Robert J. Orlowski;Rosemarie Mick

  • Dynamics of the Immune Reaction to Pancreatic Cancer from Inception to Invasion

    Carolyn E. Clark;Sunil R. Hingorani;Rosemarie Mick;Chelsea Combs

  • Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.

    Joseph L. Benci;Bihui Xu;Yu Qiu;Tony J. Wu

  • Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer

    Lauren J. Bayne;Gregory L. Beatty;Nirag Jhala;Carolyn E. Clark

  • The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes.

    Robert H Vonderheide;William C Hahn;William C Hahn;Joachim L Schultze;Lee M Nadler

  • Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy

    Jinyang Li;Katelyn T. Byrne;Fangxue Yan;Taiji Yamazoe

  • Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors

    Vinit Kumar;Laxminarasimha Donthireddy;Douglas Marvel;Thomas Condamine

  • Clinical Activity and Immune Modulation in Cancer Patients Treated With CP-870,893, a Novel CD40 Agonist Monoclonal Antibody

    Robert H. Vonderheide;Keith T. Flaherty;Magi Khalil;Molly S. Stumacher

  • Challenges and Opportunities for Pancreatic Cancer Immunotherapy

    Adham S. Bear;Robert H. Vonderheide;Mark H. O'Hara

  • CD40 Agonist Antibodies in Cancer Immunotherapy

    Robert H. Vonderheide

  • Tumor-promoting desmoplasia is disrupted by depleting FAP-expressing stromal cells

    Albert Lo;Liang-Chuan S. Wang;John Scholler;James Monslow

  • A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma

    Gregory L. Beatty;Drew A. Torigian;E. Gabriela Chiorean;Babak Saboury

  • Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma.

    Rafael Winograd;Katelyn T. Byrne;Rebecca A. Evans;Pamela M. Odorizzi

  • CD8 + T cells contribute to survival in patients with COVID-19 and hematologic cancer.

    Erin M Bange;Nicholas A Han;Paul Wileyto;Justin Y Kim

  • Immunotherapy and Prevention of Pancreatic Cancer.

    Alexander H. Morrison;Katelyn T. Byrne;Robert H. Vonderheide

  • Agonistic CD40 Antibodies and Cancer Therapy

    Robert H. Vonderheide;Martin J. Glennie

  • Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer.

    Julia Tchou;Yangbing Zhao;Bruce L Levine;Paul J Zhang

Frequent Co-Authors

Rosemarie Mick
Rosemarie Mick University of Pennsylvania
Carl H. June
Carl H. June University of Pennsylvania
Lynn M. Schuchter
Lynn M. Schuchter University of Pennsylvania
Joachim L. Schultze
Joachim L. Schultze University of Bonn
Susan M. Domchek
Susan M. Domchek University of Pennsylvania
David L. Porter
David L. Porter University of Pennsylvania
Ben Z. Stanger
Ben Z. Stanger University of Pennsylvania
Edward A. Stadtmauer
Edward A. Stadtmauer University of Pennsylvania
E. John Wherry
E. John Wherry University of Pennsylvania
Bruce L. Levine
Bruce L. Levine University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees online can open diverse career pathways. Many students consider becoming nurse practitioners specializing in mental health or acute care to complement their understanding of immune system disorders and patient care.

Exploring the cheapest online pmhnp programs is a practical step for those seeking affordable routes into psychiatric nursing while advancing their clinical knowledge. This specialization ties closely with immunological studies related to neuroinflammation and mental health conditions.

Salaries for Nurse Practitioners can vary significantly across regions. If you are considering graduate education, reviewing the dnp salary by state will help you gauge potential earnings in the Doctor of Nursing Practice field, aligning financial prospects with your career goals.

Transitioning between specialties is also possible with online programs like the fnp to acnp bridge program online, enabling Family Nurse Practitioners to move into Acute Care Nurse Practitioner roles, which often involve complex immunological cases.

Additionally, accelerated options such as the accelerated fnp programs provide a faster path to becoming a Family Nurse Practitioner, ideal for those eager to apply immunology knowledge in primary care settings sooner.

Best Scientists Citing Robert H. Vonderheide

Trending Scientists